MC4R is an important drug target due to the prevalence of mutations causing monogenic obesity and other forms of obesity [15,16], but the unusual nature of MC4R has hampered the development and application of drugs that target MC4R and demand detailed insight into the molecular mechanism of MC4R and associated mutations. Here, MC4R is linked to obesity disorder.